These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 24561431)
1. Epigenetics: prognosis based on commitment signature. McCarthy N Nat Rev Cancer; 2014 Mar; 14(3):153. PubMed ID: 24561431 [No Abstract] [Full Text] [Related]
2. Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML. Dinardo CD; Luskin MR; Carroll M; Smith C; Harrison J; Pierce S; Kornblau S; Konopleva M; Kadia T; Kantarjian H; Wertheim GB; Master SR Am J Hematol; 2017 Feb; 92(2):E14-E15. PubMed ID: 27804182 [No Abstract] [Full Text] [Related]
3. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
4. Epigenetics in AML. Melnick AM Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408 [TBL] [Abstract][Full Text] [Related]
5. An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia. Izzi V; Lakkala J; Devarajan R; Ruotsalainen H; Savolainen ER; Koistinen P; Heljasvaara R; Pihlajaniemi T Haematologica; 2017 Jul; 102(7):e245-e248. PubMed ID: 28411251 [No Abstract] [Full Text] [Related]
6. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026 [TBL] [Abstract][Full Text] [Related]
7. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia. Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717 [TBL] [Abstract][Full Text] [Related]
8. HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia. Bartholdy B; Christopeit M; Will B; Mo Y; Barreyro L; Yu Y; Bhagat TD; Okoye-Okafor UC; Todorova TI; Greally JM; Levine RL; Melnick A; Verma A; Steidl U J Clin Invest; 2014 Mar; 124(3):1158-67. PubMed ID: 24487588 [TBL] [Abstract][Full Text] [Related]
11. Increased DNA methylation of Dnmt3b targets impairs leukemogenesis. Schulze I; Rohde C; Scheller-Wendorff M; Bäumer N; Krause A; Herbst F; Riemke P; Hebestreit K; Tschanter P; Lin Q; Linhart H; Godley LA; Glimm H; Dugas M; Wagner W; Berdel WE; Rosenbauer F; Müller-Tidow C Blood; 2016 Mar; 127(12):1575-86. PubMed ID: 26729896 [TBL] [Abstract][Full Text] [Related]
12. Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction. Niemöller C; Wehrle J; Riba J; Claus R; Renz N; Rhein J; Bleul S; Stosch JM; Duyster J; Plass C; Lutsik P; Lipka DB; Lübbert M; Becker H Commun Biol; 2021 Feb; 4(1):153. PubMed ID: 33526904 [TBL] [Abstract][Full Text] [Related]
13. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia. Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548 [TBL] [Abstract][Full Text] [Related]